Canterbury Scientific

Overview

Canterbury Scientific is a New Zealand-based private investment firm focusing on early-stage healthcare and life sciences companies. The firm operates as the corporate venture arm of Canterbury Scientific Ltd., a global leader in the development, manufacturing, and supply of in vitro diagnostic (IVD) controls and calibrators. Established in 2019, CS Ventures seeks innovative IVD technologies that align with Canterbury Scientific's manufacturing specialties, aiming to diversify beyond their existing product lines. The firm's investment strategy targets novel IVD technologies incorporating proprietary biomarkers, lateral flow applications, non-standard biological fluid controls, or scalable protein purification. They prefer technologies at or beyond the human proof of concept and prototype stage (TRL 4+). CS Ventures offers flexible investment structures and is open to opportunities worldwide, excluding diabetes mellitus applications. CS Ventures has made strategic investments in Aptatek Biosciences, a U.S.-based company developing a home testing platform for Phenylketonuria (PKU), and MiMARK, a Spain-based company working on a less invasive biomarker test for endometrial cancer. These investments reflect Canterbury Scientific's commitment to advancing diagnostic innovations that address unmet medical needs and improve patient outcomes globally.

Investment Focus

• Innovative IVD technologies
• Proprietary biomarkers
• Lateral flow applications
• Non-standard biological fluid controls
• Scalable protein purification
• At or beyond human proof of concept (TRL 4+)

Portfolio Companies